Delivery Order SPE2DB20D1110-SPE2DB24FK10T
Award Date
4/9/24
Potential Completion Date
4/10/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $12,193.62 firm fixed price contract has an ultimate completion date of April 23, 2024 and is not set aside for any small business designation. Amerisourcebergen is fulfilling this order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a $36,100.70 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRELEGY ELLIPTA 200-62.5-25 60S respiratory medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for supplying a wide range of medical commodities to support military treatment programs...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The $1,526.98 delivery order has a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract with DLA Troop Support Medical, valued up to $999,999,999.00, to provide a wide range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The delivery order, valued at $2,369.21, has an ultimate completion date of April 9, 2024. This contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $47,949.34 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. (doing business as AmerisourceBergen) with the DLA Troop Support Medical. The IDC serves...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 200-62.5-25 60S medication. The $26,055.97 contract has a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $1,699.17 firm fixed price contract is for the supply of the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen holds as the primary vehicle to...
This is a $14,938.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply TRELEGY ELLIPTA 200-62.5-25 60S medication. The order is not set aside for any small business designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a wide...
This is a $17,507.31 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,068.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. This delivery order contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...